Aarti Pharmalabs Ltd

BSE
AARTIPHARM •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Aarti Pharmalabs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
75.05% Gain from 52W Low
15.8
TTM PE Ratio
Below industry Median
24.1
Price to Book Ratio
Below industry Median
3
Dividend yield 1yr %
Below industry Median
0.3
TTM PEG Ratio
PEG TTM is negative
-0.9
RSI
RSI is mid-range
40
MFI
MFI is mid-range
53

Aarti Pharmalabs Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Aarti Pharmalabs Ltd shareholding Pattern

Promoter
46.5%
Foreign Institutions
7.1%
Mutual Funds
4.7%
Domestic Institutions
11.5%
Public
35%
Promoter
46.5%
Foreign Institutions
8.3%
Mutual Funds
2.7%
Domestic Institutions
10%
Public
35.2%
Promoter
46.5%
Foreign Institutions
8.2%
Mutual Funds
2%
Domestic Institutions
9.9%
Public
35.4%
Promoter
46.3%
Foreign Institutions
8.4%
Mutual Funds
2.7%
Domestic Institutions
10.5%
Public
34.7%
Promoter
46%
Foreign Institutions
7.4%
Mutual Funds
2.7%
Domestic Institutions
10.7%
Public
35.9%
Promoter
46%
Foreign Institutions
7.7%
Mutual Funds
5.1%
Domestic Institutions
13.7%
Public
32.6%

Aarti Pharmalabs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
5
Bearish Moving Averages
11
5Day EMA
603.60
10Day EMA
610.00
12Day EMA
611.30
20Day EMA
612.20
26Day EMA
609.80
50Day EMA
592.40
100Day EMA
558.40
200Day EMA
509.00
5Day SMA
605.80
10Day SMA
613.20
20Day SMA
619.30
30Day SMA
616.90
50Day SMA
599.90
100Day SMA
538.70
150Day SMA
530.40
200Day SMA
501.50
Delivery & Volume
Resistance & Support
587.58
Pivot
Resistance
First Resistance
600.17
Second Resistance
622.58
Third Resistance
635.17
Support
First Support
565.17
Second support
552.58
Third Support
530.17
Relative Strength Index
40.04
Money Flow Index
53.01
MACD
1.49
MACD Signal
6.93
Average True Range
24.18
Average Directional Index
16.18
Rate of Change (21)
-9.75
Rate of Change (125)
11.18
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Aarti Drugs Ltd.
4711.67
430
645
Hikal Ltd.
4117.63
258.6
376.15
Orchid Pharma Ltd.
-
-
-
Shilpa Medicare Ltd.
6164.25
296.45
685
Unichem Laboratories Ltd.
3657.23
374.1
616
Ami Organics Ltd.
5356.38
1005.05
1469.55

Aarti Pharmalabs Ltd Company background

Founded in: 2019
Managing director: Narendra Jagannath Salvi
Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India.In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005 commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.9,06,26,008 Equity Shares of Rs 5/ each got listed effective January 30, 2023.
Read More

Aarti Pharmalabs Ltd FAQs

The past 1-year return of Aarti Pharmalabs Ltd [AARTIPHARM] share was 72.12. The Aarti Pharmalabs Ltd [AARTIPHARM] share hit a 1-year low of Rs. 330 and a 1-year high of Rs. 661.95.

The Mutual Fund Shareholding was 4.69% at the end of .

You can easily buy Aarti Pharmalabs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -